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Numerous studies have shown that the ability to form amyloid ﬁbrils is an inherent property of the
polypeptide chain. This has lead to the development of several computational approaches to predict
amyloidogenicity by amino acid sequences. Here, we discuss the principles governing these meth-
ods, and evaluate them using several datasets. They deliver excellent performance in the tests made
using short peptides (6 residues). However, there is a general tendency towards a high number of
false positives when tested against longer sequences. This shortcoming needs to be addressed as
these longer sequences are linked to diseases. Recent structural studies have shown that the core
element of the majority of disease-related amyloid ﬁbrils is a b-strand-loop-b-strand motif called
b-arch. This insight provides an opportunity to substantially improve the prediction of amyloids pro-
duced by natural proteins, ushering in an era of personalized medicine based on genome analysis.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Scientists have been interested in the ability of the amino acid
sequence of a protein to determine its structural state for over
50 years. The foremost efforts were devoted to studying globular
proteins [1]. Later on, researchers set their sights on the intrinsi-
cally unstructured regions of proteins making signiﬁcant progress
in the understanding of their sequence code [2,3]. However, it
has been shown that these lines of thought are insufﬁcient to
understand the complexities of protein folding. Over the last two
decades, numerous studies have demonstrated that, depending
on conditions and (or) the amino acid sequence, otherwise globular
or unstructured proteins can assemble into insoluble, stable struc-
tures of unlimited dimensions consisting of either amyloid ﬁbrils
or amorphous aggregates [4–8]. It is becoming evident that an
accurate estimation of the structural state(s) encoded by a given
amino acid sequence requires evaluation of the individual proba-
bilities of the protein to have either soluble 3D structure, an
unstructured state, or insoluble structures, as well as the likeli-
hoods of transition between the states of this triad (Fig. 1). It is
important to note that the amyloidogenic form of the insoluble
state is attracting special interest as it is linked to a number of hu-man diseases. In this review we focus on existing approaches to
predict the propensity of proteins and peptides to form amyloids
based on the analysis of their amino acid sequences.
Although amyloidogenic precursor proteins vary with respect to
their amino acid sequence and native fold, the resulting amyloid ﬁ-
brils share similar generic properties. They are typically straight, ri-
gid, between 4 and 13 nm in diameter, thermostable, protease-
resistant, and rich in b-structure [9–12]. Amyloid ﬁbrils are the
subject of special interest mainly due to their link to a broad range
of human diseases, which include, but are not limited to, type II
diabetes, rheumatoid arthritis, and perhaps most importantly,
debilitating neurodegenerative diseases such as Alzheimer’s dis-
ease, Parkinson’s disease, and Huntington’s disease. Although,
admittedly, it has been shown that in some organisms amyloid
structures can also play important, ‘‘beneﬁcial’’ roles [5]. The scope
of amyloid studies has broadened with the discovery of many pro-
teins that are not normally amyloidogenic but may be induced to
form amyloid ﬁbrils in vitro [13]. Currently, in addition to this,
the problem of amyloid formation is receiving increasing attention
from biotechnologists searching for ways to avoid the accumula-
tion of recombinant proteins into aggregates [6].
However, despite considerable interest, and much effort put to-
ward understanding of the sequence-structure relationship of
amyloid ﬁbrils, this structural state remains the least studied com-
pared with soluble structured and unstructured proteins. This
situation may be attributed in part to the limited number of stud-
ied amyloids and that the methods of determining high-resolution
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Fig. 1. Simpliﬁed scheme of relationship between the principal structural states of
proteins (soluble structured, unstructured states and insoluble amorphous aggre-
gates and amyloid ﬁbrils). Most of the known disease-related proteins form
amyloids. The likelihoods of transition between these states are denoted by the
thickness of the arrows. In the majority of cases a polypeptide chain is unfolded
prior to aggregation. A structured protein with the amyloidogenic potential must
become partially or completely unfolded to form the amyloid ﬁbril or amorphous
aggregates. In reality, the protein aggregation pathways are more complicated
involving multiple intermediate stages for both natively structured and unstruc-
tured proteins [7–8].
Table 2
Aggregation–propensity scales for individual amino acids derived by different
approaches.*
AGGRESCAN, de Groot
et al. (2006)
FoldAmyloid, Garbuzynskiy
et al. (2010)
Pawar et al.
(2005) (pH 7)
I 1.822 I 1.217 W 2.92
F 1.754 W 1.027 F 2.80
V 1.594 L 1.015 C 1.61
L 1.380 F 0.958 Y 1.03
Y 1.159 V 0.92 I 0.93
W 1.037 Y 0.851 V 0.49
M 0.910 M 0.725 L 0.25
C 0.604 C 0.568 M 1.06
—————— A 0.086 ——————
A 0.036 —————— T 2.12
T 0.159 R 0.032 A 3.31
S 0.294 H 0.025 G 3.96
P 0.334 S 0.73 H 4.31
G 0.535 Q 0.271 S 5.08
K 0.931 T 0.349 Q 6.00
H 1.033 K 0.565 N 6.02
Q 1.231 E 0.632 D 9.42
R 1.240 N 0.713 K 9.55
N 1.302 D 0.776 E 10.38
E 1.412 G 1.088 R 11.93
D 1.836 P 2.303 P 11.96
* Aggregation propensity decreases from top to bottom. Bulky apolar residues are
in bold. Dashed lines indicate the boundaries between amyloidogenic and non-
amyloidogenic amino acids (for AGGRESCAN 0.02, for FoldAmyloid triple hybrid
scale 0.062).
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be used because of the insolubility of ﬁbrils. Nevertheless, over
the last decade, numerous studies have demonstrated that just like
globular and unstructured states, the propensity to form amyloids
is coded by the amino acid sequence. Based on this data, several
methods for prediction of amyloidogenicity have been proposed.
Here we discuss these approaches and the principles behind them.
New data about amyloidogenesis which may be critical for
improvement of the current methods are also presented. The list
of described methods is not exhaustive. Our intention was to cover
most of them, selecting those that are the most popular, most ori-
ginal and diverse in terms of the basic principles, and those that
can be downloaded or used via web-servers (Table 1).
2. Methods for the prediction of amyloid ﬁbril formation
2.1. Methods that rely on individual amino acid aggregation
propensities, and the composition of amyloidogenic regions
Unlike soluble structured proteins where similar sequence
motifs correspond to 3D structural resemblance, the proteins andTable 1
Methods to predict amyloids from amino acid sequences.*
Name Basic approach
AGGRESCAN Composition of amino acids
FoldAmyloid Composition of amino acids
Zyggregator Amino acid aggregation propensities and properties o
conformation
TANGO Properties of b-structural conformation
PASTA Pairwise interactions within the b-sheets
BetaScan Pairwise interactions within the b-sheets
3D Proﬁle method
(ZipperDB)
Amyloid-like structures of short peptides
Waltz Amyloid-like structures of short peptides
NetCSSP Conformational switches
AmylPred Conformational switches
* Described in this review and accessible via internet.peptides that form amyloids have very different sequences. This
suggests that it is the amino acid composition rather than se-
quence motifs that may be of critical inﬂuence to amyloidogenici-
ty. As a result, several approaches rely on experimental or
theoretical data of individual amino acid aggregation propensities
and the evaluation of amino acid composition of amyloidogenic re-
gions [14–17]. Here, we discuss the two most recent programs,
AGGRESCAN [16] and FoldAmyloid [17], as approaches having dif-
ferent backgrounds and easily accessible by their corresponding
web-servers.
The AGGRESCAN program is based on the assumption that short
(5–11 residues) sequences or ‘‘hot spots’’ can nucleate aggregation
in peptides and proteins, and that the propensity of these ‘‘hot
spots’’ is determined by their amino acid composition. The aggre-
gation–propensity scale for individual amino acids (Table 2) was
derived from the following experimental data. The C-terminus of
the 42-residue long human Ab-peptide was linked by 12 residue
fragment to a green ﬂuorescent protein (GFP) [18]. It was shown
that Escherichia coli cells express a high amount of this fusion pro-
tein but exhibit little ﬂuorescence, indicating that the presence of
the aggregation–prone Ab42 peptide interferes with the correct
folding of the GFP and thus with the emission of ﬂuorescence.Server/Website
http://bioinf.uab.es/aggrescan/
http://bioinfo.protres.ru/fold-amyloid/oga.cgi
f b-structural http://www-vendruscolo.ch.cam.ac.uk/
zyggregator.php
http://tango.crg.es/
http://protein.bio.unipd.it/pasta/
http://groups.csail.mit.edu/cb/betascan/
betascan.html
http://services.mbi.ucla.edu/zipperdb/submit
http://waltz.switchlab.org/
http://cssp2.sookmyung.ac.kr/index.html
http://biophysics.biol.uoa.gr/AMYLPRED/
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substituted by all other amino acids was tested and these results
were used to create the aggregation–propensity scale for amino
acids (Table 2). A ‘‘hot spot’’ is deﬁned as a region that contains ﬁve
or more consecutive residues with an average aggregation propen-
sity value higher than the average of the 20 naturally occurring
amino acids weighted by their frequencies in the Swiss-Prot
database.
The FoldAmyloid program, like AGGRESCAN, uses the assump-
tion that short sequences of 5 residues are sufﬁcient for amyloido-
genesis and applies a sliding window averaging technique to ﬁnd
them [17]. The main difference is the derivation of individual ami-
no acid aggregation propensities from the statistical analysis of
known 3D structures of globular proteins. It was shown that two
characteristics (the mean number of atom–atom contacts per res-
idue, and the mean number of backbone H-bonds per residue) cor-
relate well with amyloidogenicity. The FoldAmyloid program
predicts amyloidogenic regions using either one of these amino
acids scales (contacts, backbone H-bonds of acceptors or donors),
or a hybrid scale which includes all three (Table 2). The cut-off val-
ues optimal for amyloidogenic prediction were selected based on
receiver operator characteristic (ROC) curves obtained by tests on
sets of the known amyloidogenic and non-amyloidogenic peptides.
2.2. Methods that rely on individual amino acid aggregation
propensities and the properties of b-structural conformation
The major building blocks of amyloids are b-strands, which
have an extended conformation with conserved apolar and vari-
able (generally polar) residues alternating along the chain. A num-
ber of methods use this information to improve the prediction of
amyloidogenic regions.
One of them is the Zyggregator method that takes into consid-
eration patterns of seven or more residues with alternating apolar
and polar residues [19]. To calculate the aggregation propensity,
this method also uses a set of physico-chemical properties of ami-
no acid residues such as hydrophobicity, charge, and the propen-
sity to adopt a-helical or b-structural conformations. These
properties were derived by ﬁtting the expression used to calculate
the aggregation propensity on a database of mutational variants for
which aggregation was measured in vitro [14,20]. Zyggregator also
considers the ﬂanking residues (‘‘gatekeeper’’ residues) of a given
sliding window for the presence of charged residues of the same
sign, as this may reduce aggregation by electrostatic repulsion. In
a majority of cases a polypeptide chain should be unfolded to
aggregate. Therefore, when applied to structured proteins, predic-
tion methods need to estimate probability of the protein or parts of
it to be unstructured. Zyggregator has this option, evaluating the
local stability of protein structure by CamP program [21].
The TANGO predictor of b-structural aggregation [22] uses a
statistical mechanics approach to make secondary structure pre-
dictions. For a given sequence this method considers different
competing conformations (random coil, b-turn, a-helix, and b-
sheets) and predicts which is most likely to occur. The algorithm
is based on the following assumptions: (i) a particular amino acid
sequence is aggregation–prone if it has high propensity to form b-
structure, (ii) all residues of the b-region are buried in the hydro-
phobic interior of the aggregate, (iii) complementary charges in
the selected window establish favorable electrostatic interactions,
and (iv) deviating from neutral net charge disfavors aggregation of
the peptide. TANGO considers that peptides have a tendency for
aggregation when they possess segments of at least ﬁve consecu-
tive residues in the predicted b-aggregate conformation. Zyggrega-
tor and TANGO both take into account the effect of physico-
chemical conditions such as pH, temperature, ionic strength, and
the triﬂuorethanol concentration on aggregation.2.3. Methods that rely on pairwise side-chain to side-chain
interactions within the b-sheets
A b-strand cannot exist alone. It is stabilized only when in-
volved in b-sheets, where several b-strands interact with each
other via peptide group H-bonds. Although the main interaction
occurs by the H-bonds, side-chain to side-chain interactions of
the adjacent b-strands may provide additional sequence speciﬁc
stability. Consideration of these side-chain interactions may im-
prove the correct prediction of the b-strand regions and their
arrangement within the b-sheets. Therefore, some methods use
the data on the propensity of pairwise side-chain side-chain inter-
actions within the b-sheets to predict amyloidogenicity.
For example, the PASTA program [23,24] uses a non-redundant
set of known globular structures to count for pairs of amino acids
that form contacts (Ca atoms less than 6.5 Å) between the adjacent
b-strands of the b-sheets. The occurrence of the amino acid pairs
was analyzed separately for parallel and anti-parallel b-strands. Fi-
nally, the pairwise scores were calculated by using a Boltzmann en-
ergy function derived from the amino acid contact occurrence. The
score was used to predict localization and a preferable 3D arrange-
ment of b-strand pairs (parallel or antiparallel, shifted or in register)
in a given protein. It was assumed that protein can form amyloids
via interaction of a short (four residues ormore) b-structural region.
The BETASCAN program, also relies on b-pairing propensities,
speciﬁcally focusing on the parallel orientation of b-strands, as it
occurs most frequently in amyloid ﬁbrils [25]. It calculates the like-
lihood scores for potential b-strands and strand-pairs based on cor-
relations observed in known amphipathic parallel b-sheets with
one face contacting hydrophibic interior and the other face exposed
to the solution. The likelihood of a sequence to form parallel b-
strands is calculated as the propensity for this sequence to occur
as a b-strand multiplied by its propensity to form b-strand pairs.
BETASCAN then uses a hill-climbing algorithm to determine if rota-
tion of the b-strands by 180 around its axis, the addition or sub-
traction of residues to the ﬁbril forming region, or the shifting the
ﬁrst or second b-strand pairs can give rise to structures more likely
to form parallel b-strands and therefore predicted to be more amy-
loidogenic. BETASCAN uses a b-strand window of 3–13 residues.
2.4. Methods inspired by the establishment of the amyloid-like
structures of short peptides
The approaches mentioned above were based on the analysis of
known 3D globular structures. However, since 2005, several crystal
structures in which short peptides engage in amyloid-like interac-
tions have been determined [26,27]. These structures provided de-
tails of side-chain interactions inside the double b-sheet, which is
also called a ‘‘cross-b spine’’. The basic template represents two
parallel b-sheets oriented antiparallel to one another with the
interface formed by the like-sides of each sheet. The improved
understanding of the interactions of b-strands in microcrystals of
short amyloidogenic peptides inspired new approaches.
The 3D proﬁle method [28] uses the ‘‘cross-b spine’’ structure
formed by NNQQNY fragment from the sup35 prion protein of Sac-
charomyces cerevisiae [26]. Initially, a set of 3D templates were
built from the crystal structure of the peptide NNQQNY by small
displacements of one of the two interacting b-sheets relative to
the other. Each six-residue peptide of an analyzed protein is
mapped onto these templates and the energy of each sequence
to the proﬁle mapping was evaluated using the ROSETTADESIGN
program [29,30]. A region is considered to be amyloidogenic if
the energy evaluated in this manner is below a threshold value.
To test the performance of the program the AmylHex database of
67 known ﬁbril-forming and 91 non-ﬁbril-forming hexapeptides
was compiled from the literature.
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templates generated by small displacements of the crystal struc-
ture of peptide NNQQNY [26]. However, residue-based statistical
potential calculations, instead of ROSETTADESIGN analysis were
applied to evaluate the energy of each sequence mapped onto
these templates.
Another method, called Waltz, [32] used the AmylHex dataset
[28] not for benchmarking, but as a learning set to generate the po-
sition speciﬁc scoring matrix (PSSM) of hexapeptides for identiﬁca-
tion of amyloid-forming sequences. For this purpose, the AmylHex
dataset was supplemented by a number of new experimentally
determined amyloidogenic and non-amyloidogenic peptides. In
addition to the PSSM, 19 physical properties of amino acids (such
as b-structure propensity, and hydrophobicity) that strongly corre-
lated with their frequencies in the positive and negative hexapep-
tide learning sets were selected to predict amyloidogenicity.
Finally, Waltz program uses a position speciﬁc pseudo energy ma-
trix derived as follows. The crystal structure of Sup35 GNNQQNY
peptide [26] was reduced to poly-alanine and all possible combina-
tions of naturally occurring amino acids were made. The structures
were optimized and their energy was estimated by using the FoldX
program [33]. The three terms (PSSM, physicochemical and struc-
ture-derived) are combined in the composite scoring function used
to predict the amyloidogenicity.
2.5. Methods that estimate probability of structured proteins to be
partially unfolded
To form cross-b amyloids, a polypeptide chain with high amy-
loidogenic potential needs to be unstable within its native 3D
structure or be completely unfolded. Indeed, experimental studies
show that most of the known amyloid-forming sequences (for
example, amyloid-b, a-synuclein, Ure2p, and Sup35p) are unstruc-
tured in their non-amyloid state. Proteins that fold into soluble 3D
structures may also contain a number of amyloidogenic regions
hidden in their structures. Signiﬁcant efforts have been dedicated
to the identiﬁcation of such hidden regions (also known as ‘confor-
mational switches’ or ‘‘chameleon’’ sequences) within globular
proteins that are innocuous in their normal state [34].
Some methods developed for prediction of amyloidogenicity
address this problem. For example, the Zyggregator method in-
cludes an option to evaluate the local stability of protein structure
[21]. The Net-CSSP method (contact-dependent secondary struc-
tural propensity) [35,36] quantiﬁes the inﬂuence of tertiary inter-
actions on secondary structure preference by using an artiﬁcial
neural network-based algorithm and seeks to ﬁnd short regions
with a hidden potential to form b-sheets.
Another web-based tool, AmylPred, combines the results of
amyloidogenicy predictions with the SecStr secondary structure
prediction tool [37]. The SecStr tool uses six different algorithms
to give a secondary structure prediction. If it predicts that amino
acid stretches have ambivalent propensities for a-helix and b-
strand, they are considered to be regions with potential ‘conforma-
tional switches’. After that several approaches such as, FoldAmy-
loid [17] and scanning of proteins with amyloidogenic motif
extracted from the known ﬁbril-forming peptides [38] are applied
to the sequence. Regions of the structured protein that are simul-
taneously identiﬁed as the ‘conformational switches’ and highly
amyloidogenic considered to be the amyloidogenic determinants.3. Performance of methods
To evaluate prediction methods, benchmark datasets of
amyloid-forming and non-forming sequences are required. When
doing so, the primary problem is the limited number of knownamyloid-forming proteins. Today, only about 20 amyloid-forming
proteins are known to be linked to diseases [39]. Although datasets
can be enriched by adding known mutants of these proteins, this is
not a solution, as the datasets become biased towards certain over-
represented sequences. Moreover, prediction methods are de-
signed to exclusively detect cross-b amyloids, whereas disease-
related ﬁbrils are heterogeneous in terms of their 3D structure.
Some are formed by stacks of native or refolded globular struc-
tures, [40–42] and do not necessarily exhibit cross-b structure.
Care must also be taken when developing the negative set. It is
tempting to use globular proteins as they are soluble and non-
amyloidogenic. Most prediction programs, however, operate using
only sequence information, and will incorrectly predict amyloido-
genic candidates that are in fact hidden inside the protein struc-
ture. Furthermore, when one considers that different amyloid-
forming proteins form ﬁbrils at different conditions (concentration,
ionic strength, pH, etc.) it becomes evident that the task to con-
struct testing datasets of high quality is extremely challenging.
Most of the methods use datasets of short peptides. The reasons
are that short peptides can be synthesized easily and tested in the
same or similar experimental conditions for the formation of amy-
loid ﬁbrils. Moreover, soluble short peptides can be used directly as
a non-amyloidogenic set. As these peptides are unfolded, they do
not have the problem of structurally hidden regions found in
folded proteins. Finally, the usage of short peptides is in agreement
with the predominant paradigm underlying existing prediction
algorithms: short (about 6 residues) regions are sufﬁcient for form-
ing amyloid ﬁbrils of full-length proteins.
There are several popular benchmark datasets of short peptides.
The ﬁrst large dataset was compiled for the testing of the TANGO
algorithm [22] and consisted of 78 amyloidogenic and 172 non-
amyloidogenic peptides mostly from human disease related pro-
teins. Peptides were considered to be aggregating when their circu-
lar dichroism or NMR spectra had concentration dependence in the
range between 1 lM and 5 mM, or when binding to an amyloid-
reporting dye (thioﬂavine T) was observed. Another set of experi-
mentally determined amyloid-forming peptides was selected from
the literature and used to test AGGRESCAN program [16]. The most
frequently used data set is AmylHex. It contains 158 six-residue
peptides of which 67 have been shown to form ﬁbrils and 91 are
soluble [28]. A majority of the dataset consists of mutants of STVIIE
peptide, as well as hexapeptides and their mutants from amylin,
tau, insulin, b2-microglobulin. Recently, the AmylHex dataset
was supplemented by 49 new amyloid-forming and 71 non-amy-
loid-forming hexapeptide sequences [32] to bring the total number
of amyloid forming hexapeptides to 116 positive and 103 negative
sequences. Several other predictors of amyloidogenicity used one
of the datasets mentioned above or their combinations.
Fig. 2 shows our benchmarking results for three programs
(TANGO, AGGRESCAN and Waltz) on a combined set of the se-
quences from all the datasets mentioned above. The tested pro-
grams display good results, correctly identifying 65%, 71% and
80% of the amyloid-forming peptides, correspondingly, and having
only 17%, 25% and 15% of false positives in the set of non-amyloi-
dogenic peptides. Waltz performs better than the other programs,
however, it is necessary to remember that a large number of pep-
tides from the combined dataset were used by this program as a
training set [32].
The other approach typically used to demonstrate the power of
the methods was the prediction of known pathogenic or protective
mutants of amyloid-forming proteins to demonstrate the ability to
predict the observed change in the amyloidogenicity [16,22]. In
addition, the programs are tested for the prediction of locations
of amyloid-forming regions in longer peptides (30–40 residues)
and full-length proteins. Especially those, with a natively unfolded
monomeric state, and experimentally veriﬁed locations of amyloid
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Fig. 2. Comparison of ROC curve performance on the combined dataset composed
of sequences compiled by the authors of TANGO, AGGRESCAN and AmylHex
(including the sequences added by the authors of the Waltz program). The
combined dataset contains 243 amyloid forming and 333 non-forming sequences.
The programs were chosen for their ability to analyse multiple sequences
simultaneously at their web-servers.
Table 3
Performance of different methods on datasets of proteins.*
Program** True positive rate False positive rate
Waltz 0.666 (12/18) 0.346 (18/52)
Tango 0.277 (5/18) 0.500 (26/52)
Aggrescan 0.722 (13/18) 0.769 (40/52)
FoldAmyloid 0.388 (7/18) 0.750 (39/52)
AmylPred 0.833 (15/18) 0.673 (35/52)
True positive rate: (Number of true positives)/(Total number of amyloid-forming
sequences).
False positive rate: (Number of false positives)/(Total number of non-amyloidogenic
sequences).
* The set of amyloid-forming sequences is composed of proteins or peptides known
to form amyloids in vivo that were taken from literature with the following criteria:
they are non-globular in their native state, form cross-beta ﬁbrils under physio-
logical conditions, and their sequences are longer than 20 amino acids. This set
contains 18 sequences (see Supplementary data).The negative set was extracted
from the DisProt database of disordered proteins (Vucetic et al., 2005) with the
following criteria: sequences are disordered in their entirety and have less than 150
residues. The negative set contains 52 sequences (see Supplementary data).
** The default settings of the web-servers were used.
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such tests are amyloid-b, a-synuclein and amylin. In Fig. 3, the pre-
dictions of amyloidogenic ‘‘hot spots’’ in ﬁbril-forming regions of
amyloid-b and Het-s prion are shown. The programs generate sat-
isfactory predictions for amyloid-b peptide, while in the Het-s
prion region, the predictions are less credible. For example, Waltz
program does not ﬁnd any amyloid-forming region within the
Het-s prion domain. This can be explained by the absence of
the Het-s peptides in its training set, or by some differences of
the Het-s ﬁbril structure from the typical cross-b amyloids. The
amyloid-b structure represents a stack of identical peptides, but
the Het-s cross-b ﬁbril is formed by the repetitive element with
two slightly different beta-strands alternating along the ﬁbril axis.
The performance of the programs can be summarized thusly.
They accurately predict short amyloid-forming peptides, and are
adept at determining experimentally established ﬁbril-formingWaltz   AGGRESCAN FoldAmyloid TANGO
Het-s Prion (218-289)
Amyloid-β
Fig. 3. Prediction of localization of amyloidogenic regions in the Het-s prion
domain (218–289) and in amyliod-b peptide. Lines with arrows below the sequence
denote the known regions involved in the ﬁbril structure. The b-strands are shown
by arrows.regions in full-length proteins. However, most of the methods gen-
erate a large number of false positives when applied to the se-
quences of longer than 30–40 residues. Another problem of these
methods is the over prediction of amyloids in hydrophobic regions
and their poor predictive capability of amyloidogenic sequences rich
in polar Gln and (or) Asn. This shortcoming can be explained by the
fact that some methods use aggregation propensities values ob-
tained from the analysis of globular proteins which have the hydro-
phobic residues as the predominant structure-stabilizing factor.
It must be emphasised that the eventual goal for all methods be
the correct prediction of amyloid ﬁbril formation in naturally
occurring proteins and peptides. However, the existing programs
yield unconvincing results, generally predicting a sizable number
of false positives (Table 3).
4. New structural data as a basis for improvement of the
algorithms
Our retrospective analysis of the methods for prediction of amy-
loidogenicity reveals that an appropriate consideration of the
structural properties of amyloids is a key factor for improving of
the performance of these programs. Indeed, the progression of
known methods shows a pattern of increasing usage of structural
information. They started with the consideration of the amino acid
composition of proteins, then moved onto the b-structural pattern
representing alternation of polar and apolar residues, then to the
analysis of side-chain interactions within a b-sheet, before ﬁnally
supplementing it with the analysis of side-chain packing between
the b-sheets.
Recently, new experimental approaches have shed more light
on the details of the 3D structural arrangement of amyloid ﬁbrils.
Progress was made by the application of new experimental
techniques such as solid state nuclear magnetic resonance, cryo-
electron microscopy, scanning transmission electron microscopy
mass measurements, and electron paramagnetic resonance spec-
troscopy, in conjunction with more established approaches such
as X-ray ﬁber diffraction, conventional electron microscopy, and
optical spectroscopy [43–47] As a result, it was shown that a
majority of structural models of disease-related amyloid ﬁbrils
can be reduced to a so called ‘‘b-arcade’’ (Fig. 4) [48]. This
fold represents a columnar structure produced by stacking of b-
strand-loop-b-strand motifs called ‘‘b-arches’’ [49]. Each b-arcade
has a double-layer structure in which 2 parallel in-register b-
sheets face each other. The side chains protruding from opposing
b-sheets form tight inter-digitated packing. Variations of b-arch
β(a) (b)
(c)
-arc
β-arcade
β-arches
N
C
C N
N
C
Fig. 4. The b-arcade as a common structural motif of disease-related amyloid ﬁbrils.
(a) Overall view of the b-arcade protoﬁbril with the ﬁrst b-sheet in blue and the
second one in magenta. (b) Detailed view of the b-arcade arrangement. The
structure is formed by the axial stacking of identical b-arches consisting of 2 long b-
strands (shown as arrows) connected by a b-arc. The arches are H-bonded (thin
lines) along the ﬁbril axis and form a double layer of parallel b-sheets. (c) An
example demonstrating that amyloidogenic sequence motifs in short peptides can
be non-amyloidogenic in the b-arcade structure. In the ﬁrst case, an axial view of a
short double layer formed by identical parallel b-sheets is shown. The short b-
strands have a sequence motif with positively (blue circle) and negatively (red
circle) charged residues separated by one apolar residue (black circle) on their
interior side. The charged side chains can form favourable salt bridges. In contrast,
such a sequence motif within the b-arcade structure should be energetically
unfavourable due to the location of uncompensated charges incapable of forming
salt bridges inside the apolar environment. For the sake of clearness the outside side
chains are not shown.
1094 A.B. Ahmed, A.V. Kajava / FEBS Letters 587 (2013) 1089–1095arrangements may lead to either single b-arcade structures [50,51],
superpleated b-structures with several adjacent b-arcades [52] or
b-arches within the b-solenoids [53].
The prevalence of b-arches in disease-related amyloids will cer-
tainly have implications for identifying amyloidogenic sequences.
The amyloidogenic region capable of forming the b-arcade struc-
ture needs to be over 15–20 residues. This may lead to the revision
of the paradigm that short 6–10 residue segments of protein can
initiate its amyloidosis. In addition, one can imagine cases where
methods based on the prediction of short amyloidogenic regions
will fail to detect the b-arch regions of high amyloidogenic poten-
tial (see for example, Fig. 4).
5. Conclusions
Several computational methods have been developed to predict
the propensity of polypeptides to form amyloids based on sequence
analysis.Manyof themethodshave rendered excellent performance
capabilities in the numerous tests. These algorithms use the
assumption that a short sequence (about 6 residues) is sufﬁcient
to trigger the amyloid formation of a given protein. Consequently,
they achieve their best results among short peptides. However, the
analysis of short peptides is largely un-equivalent to the in vivo for-
mation of disease related amyloids. Indeed, peptides of less than
about 15 residues rarely reach ﬁbril-forming concentrations in hu-
man cells, as once produced, they are rapidly degraded by endoge-
nous proteases [54]. Although it is true that a short ﬁbril-forming
region may occur within a longer polypeptide chain, fusion of short
amyloidogenic peptides with soluble proteins has not yielded con-
vincing results, only triggering ﬁbrillation at high concentrations
[55,56]. Additionally, known naturally occurring amyloid-formingproteins have amyloidogenic regions that are longer than 15 resi-
dues. Finally, recent experimental techniques reveal that the mini-
mal structural element of the majority of disease-related amyloid
ﬁbrils is a columnar structure produced by stacking of b-strand-
loop-b-strand motifs spanning over 15–20 residues.
Given these considerations, we may expect the development of
new bioinformatics tools with improved prediction when applied
to the long peptides or full-length proteins. These kinds of tools
are particularly relevant to the disease-related amyloids and espe-
cially needed because currently no reliable ways to diagnose the
early stages of such diseases are available. Furthermore, thanks
to a radical drop in the cost of sequencing an individual’s genome,
such bioinformatics tools are becoming extremely timely. With
further research, an accurate risk proﬁle might enable individuals
to take steps to prevent diseases for which they are at increased
risk based on genetics.Acknowledgements
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